These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 751804

  • 1. Quantitative and qualitative estimation of urinary kallikrein in a patient with Bartter's syndrome.
    Yamada K, Watanabe M, Nishikawa T, Mikami K, Shirai K, Tamura Y, Yamamoto M, Kumagai A, Matsuda Y, Moriya H.
    Endocrinol Jpn; 1978 Dec; 25(6):583-9. PubMed ID: 751804
    [Abstract] [Full Text] [Related]

  • 2. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV, Wohltmann H, Privitera PJ, Hurwitz G, Margolius HS.
    Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
    [Abstract] [Full Text] [Related]

  • 3. Urinary kallikrein excretion in Bartter's syndrome.
    Lechi A, Covi G, Lechi C, Mantero F, Scuro LA.
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1175-8. PubMed ID: 993321
    [Abstract] [Full Text] [Related]

  • 4. Some aspects of urinary kallikrein in a patient with Bartter's syndrome.
    Tamura Y, Matsuda Y, Yamada K, Takagi T, Nishikawa T, Watanabe M, Mikami K, Moriya H, Kumagai A.
    Adv Exp Med Biol; 1979 Nov; 120B():515-24. PubMed ID: 517245
    [No Abstract] [Full Text] [Related]

  • 5. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult.
    Lechi A, Mantero F, Opocher G, Armanini D, Lechi C, Covi G.
    J Endocrinol Invest; 1981 Nov; 4(1):17-20. PubMed ID: 7016967
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome.
    Rodriguez-Portales JA, Lopez-Moreno JM, Mahana D.
    Hypertension; 1985 Nov; 7(6 Pt 1):1017-22. PubMed ID: 2416684
    [Abstract] [Full Text] [Related]

  • 7. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H, Kawasaki T, Okumura M, Asano T, Abe K, Arakawa K.
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract] [Full Text] [Related]

  • 8. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.
    Vinci JM, Gill JR, Bowden RE, Pisano JJ, Izzo JL, Radfar N, Taylor AA, Zusman RM, Bartter FC, Keiser HR.
    J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139
    [Abstract] [Full Text] [Related]

  • 9. On the pathogenetic role of prostaglandins in Bartter's syndrome.
    Nielsen I, Hesse B, Christensen P.
    Acta Med Scand Suppl; 1979 Jun; 625():135-40. PubMed ID: 285569
    [Abstract] [Full Text] [Related]

  • 10. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH, Hewitt GJ, Mitchell MD.
    Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
    [Abstract] [Full Text] [Related]

  • 11. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T, Fujimaki M, Senba S, Saito I, Konishi K.
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [Abstract] [Full Text] [Related]

  • 12. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride.
    Sato M, Abe K, Yasujima M, Otsuka Y, Chiba S, Haruyama T, Yoshinaga K, Saito T, Kabuki J.
    Tohoku J Exp Med; 1980 Jun; 131(2):151-9. PubMed ID: 7404582
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome.
    Hornych A, Krief C, Aumont J.
    Uremia Invest; 1980 Jun; 9(2):203-10. PubMed ID: 3870249
    [Abstract] [Full Text] [Related]

  • 17. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
    Fichman MP, Telfer N, Zia P, Speckart P, Golub M, Rude R.
    Am J Med; 1976 May 31; 60(6):785-97. PubMed ID: 798488
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT, Aurecchia SA, Sindler BH, Melby JC.
    J Clin Pharmacol; 1982 May 31; 22(11-12):505-12. PubMed ID: 6761369
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.